Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration

Dario Coletti1, Viviana Moresi, Sergio Adamo

  • 1Brookdale Department of Molecular, Cell and Developmental Biology, Mount Sinai Medical School, New York, New York 10029, USA.

Genesis (New York, N.Y. : 2000)
|September 15, 2005
PubMed

Insights

Scientists created a new method to study muscle wasting using gene transfer of tumor necrosis factor-alpha (TNFalpha). This model effectively induces muscle atrophy and inhibits muscle regeneration in mice.

Area of Science:

  • Biomedical Research
  • Molecular Biology
  • Physiology

Background:

  • Chronic diseases elevate inflammatory cytokines, causing severe muscle wasting.
  • Existing in vivo cytokine models are limited for studying muscle wasting in new mouse mutants.

Purpose of the Study:

  • To develop a novel and simple in vivo model for inducing adult mouse skeletal muscle wasting.
  • To investigate the effects of murine tumor necrosis factor-alpha (mTNFalpha) on muscle atrophy and regeneration.

Main Methods:

  • Direct gene transfer of an expression vector encoding secreted murine tumor necrosis factor-alpha (mTNFalpha) into adult mice.
  • Monitoring body weight loss, Atrogin1 upregulation, and muscle atrophy.
  • Assessing the impact of mTNFalpha gene transfer on muscle regeneration following injury.

Main Results:

  • Gene transfer successfully induced elevated circulating mTNFalpha levels.
  • Induced significant body weight loss, Atrogin1 upregulation, and muscle atrophy, even in distant muscles.
  • Demonstrated significant inhibition of muscle regeneration after injury.

Conclusions:

  • TNFalpha is a potent inducer of cachexia (muscle wasting).
  • TNFalpha significantly inhibits myogenesis (muscle formation) in vivo.
  • The developed gene transfer model is effective for studying muscle wasting and TNFalpha's role.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...